作者:Helmut Haning、Michael Woltering、Ulrich Mueller、Gunter Schmidt、Carsten Schmeck、Verena Voehringer、Axel Kretschmer、Josef Pernerstorfer
DOI:10.1016/j.bmcl.2005.02.028
日期:2005.4
Novel heterocycle-fused thyromimetics are presented carrying indoles or indazoles instead of the phenolic group in T3. Potent agonists were identified in both series. SAR trends are examined and found to be mostly consistent with previously published thyromimetics. Moderate THRbeta selectivity (approx. 10-fold) was observed in the indole series using isoform-selective transient THR transfection assays
提出了带有吲哚或吲唑而不是T3中的酚基的新型杂环稠合的胸腺嘧啶。在两个系列中均鉴定出强效激动剂。检查了SAR趋势,发现它与以前发表的甲状腺素动力学基本一致。使用同工型选择性瞬时THR转染试验,在吲哚系列中观察到中等的THRbeta选择性(约10倍)。